Novavax vaccine found effective against new UK COVID-19 variant
Novavax vaccine found effective against new UK COVID-19 variant
Novavax has become the first immune dose to definitively confirm protection against the new variant of the deadly virus which was detected in the UK late last year.
advertisement
UPDATED: January 29, 2021 17:20 IST
A late-stage clinical trial involving over 15,000 people in the UK found that the vaccine produced by American firm Novavax is 89.3% effective in preventing coronavirus and offered 85.6% protection against the new British strain of COVID-19. (Reuters FILE)
Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has become the first immune dose to definitively confirm protection against the new variant of the deadly virus which was detected in the UK late last year.